Crescendo Biologics

Orum Therapeutics

This biopharmaceutical company develops antibody-degrader conjugates to treat cancer and immune diseases for patients and pharmaceutical partners.

Mestag Therapeutics

This company develops antibody therapies targeting fibroblast immunology for patients with cancer and inflammatory diseases.

Creasallis

This biotech company develops a technology that improves the penetration of antibody-based drugs into solid tumours for pharmaceutical and biopharmaceutical organisations.

Amphista Therapeutics

This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Adcendo

This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.

ybiologics

The company develops antibody-based therapeutics and immuno-oncology drugs for pharmaceutical partners and the global healthcare sector.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.